188 related articles for article (PubMed ID: 359269)
1. Lytic activity of a new cephalosporin, cefuroxime, against gram-negative bacteria.
Russell AD; Tottle PC
Chemotherapy; 1978; 24(6):354-9. PubMed ID: 359269
[TBL] [Abstract][Full Text] [Related]
2. A model system to demonstrate that beta-lactamase-associated antibiotic trapping could be a potential means of resistance.
Gutmann L; Williamson R
J Infect Dis; 1983 Aug; 148(2):316-21. PubMed ID: 6310004
[TBL] [Abstract][Full Text] [Related]
3. Beta-lactamase stability and antibacterial activity of cefpirome alone and in combination with other antibiotics.
Bakhtiar M; Selwyn S
Drugs Exp Clin Res; 1989; 15(10):477-82. PubMed ID: 2698794
[TBL] [Abstract][Full Text] [Related]
4. [Study of in vitro activity of 3 cephalosporins and their combination with 2 beta-lactamase inhibitors against 4 enterobacteria strains producing extended spectrum beta-lactamase].
Cattoen C; Duflos D; Bouillet L; Chatelain C; Mazars E
Pathol Biol (Paris); 1997 May; 45(5):425-9. PubMed ID: 9296097
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of cefetamet against enterobacteria expressing an SHV-5-type beta-lactamase.
Tzouvelekis LS; Prinarakis EE; Gazouli M; Miriagou V; Tzelepi E; Legakis NJ
Chemotherapy; 1996; 42(5):324-8. PubMed ID: 8874970
[TBL] [Abstract][Full Text] [Related]
6. [Activity of 9 beta-lactam antibiotics combined with clavulanic acid or sulbactam against the strains of broad-spectrum beta-lactamase (CTX-1) producing Enterobacteriaceae isolated at the Henri Mondor Hospital].
Legrand P; Soussy CJ; Orsoni A; Brickley X; Duval J
Pathol Biol (Paris); 1988 May; 36(5):425-9. PubMed ID: 3043338
[TBL] [Abstract][Full Text] [Related]
7. Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.
Pournaras S; Vrioni G; Neou E; Dendrinos J; Dimitroulia E; Poulou A; Tsakris A
Int J Antimicrob Agents; 2011 Mar; 37(3):244-7. PubMed ID: 21236643
[TBL] [Abstract][Full Text] [Related]
8. The activity of cefotiam on beta-lactamase-producing bacteria in an in-vitro model.
Wiedemann B; Seeberg AH
J Antimicrob Chemother; 1984 Feb; 13(2):111-9. PubMed ID: 6323374
[TBL] [Abstract][Full Text] [Related]
9. HR 756, the syn isomer of a new methoxyimino cephalosporin with unusual antibacterial activity.
Chabbert YA; Lutz AJ
Antimicrob Agents Chemother; 1978 Nov; 14(5):749-54. PubMed ID: 31836
[TBL] [Abstract][Full Text] [Related]
10. Emergence of beta-lactam multiresistant variants of gram-negative bacilli in the presence of cefotaxime.
Svarva PL; Lyng RV; Maeland JA
Scand J Infect Dis; 1985; 17(4):387-91. PubMed ID: 3911375
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the substrate specificities of the -lactamases from Klebsiella aerogenes 1082E and Enterobacter cloacae P99.
Marshall MJ; Ross GW; Chanter KV; Harris AM
Appl Microbiol; 1972 Apr; 23(4):765-9. PubMed ID: 4553144
[TBL] [Abstract][Full Text] [Related]
12. Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2007.
Jean SS; Lee WS; Bai KJ; Lam C; Hsu CW; Yu KW; Liao CH; Chang FY; Ko WC; Wu JJ; Chen YH; Chen YS; Liu JW; Lu MC; Liu CY; Chen RJ; Hsueh PR
J Microbiol Immunol Infect; 2015 Feb; 48(1):85-91. PubMed ID: 23973410
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the in vitro activity of a new cephalosporin, cefuroxime, and cephalothin against 810 clinical isolates.
Skar AG; Midtvedt T; Dahl O
NIPH Ann; 1979 Dec; 2(2):31-40. PubMed ID: 398460
[TBL] [Abstract][Full Text] [Related]
14. Bactericidal killing activities of cefepime, ceftazidime, cefotaxime, and ceftriaxone against Staphylococcus aureus and beta-lactamase-producing strains of Enterobacter aerogenes and Klebsiella pneumoniae in an in vitro infection model.
Palmer SM; Kang SL; Cappelletty DM; Rybak MJ
Antimicrob Agents Chemother; 1995 Aug; 39(8):1764-71. PubMed ID: 7486916
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection.
Stürenburg E; Sobottka I; Noor D; Laufs R; Mack D
J Antimicrob Chemother; 2004 Jul; 54(1):134-8. PubMed ID: 15150168
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of six beta-lactam antibiotics against non-beta-lactamase producing and producing enterobacteria and antibiotic resistance transfer.
Scioli C; Esposito S; Martinelli R
Boll Ist Sieroter Milan; 1984 Sep; 63(4):338-47. PubMed ID: 6335045
[TBL] [Abstract][Full Text] [Related]
17. In vitro studies with Bay V 3522, a new oral cephalosporin.
Thomson KS; Sanders CC; Sanders WE
Drugs Exp Clin Res; 1991; 17(3):165-73. PubMed ID: 1914843
[TBL] [Abstract][Full Text] [Related]
18. Detection of beta-lactamase activity with nitrocefin of multiple strains of various microbial genera.
Uri JV
Acta Microbiol Hung; 1985; 32(2):133-45. PubMed ID: 3933272
[TBL] [Abstract][Full Text] [Related]
19. [Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates].
Xiong Z; Zhu D; Zhang Y; Wang F
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1476-9. PubMed ID: 12509910
[TBL] [Abstract][Full Text] [Related]
20. [Antibacterial effect of cefixime in the presence of the type of beta-lactamases produced by Enterobacteriaceae].
Philippon A; Jarlier V; Legrand P; Fournier G; Nicolas MH; Duval J
Presse Med; 1989 Oct; 18(32):1560-6. PubMed ID: 2530532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
